Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,948
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Dallas TX, Plano TX, Austin TX, Houston TX,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07052903
Phase 3, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Dallas TX, Richardson TX, Fort Worth TX, Lawton OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase 2, Phase 3, Recruiting
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
for
Carcinoma, Squamous Cell
Location: Dallas TX, Aurora CO, Louisville KY, Columbia SC,
Sponsor: Introgen Therapeutics
Sex: All
Age: 18+
Code: NCT00041613
Phase 3, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Get alerts for new trials in your area by subscribing now
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Dallas TX, Houston TX, Aurora CO, Arlington Heights IL,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: Dallas TX, St Louis MO, Indianapolis IN, Rochester MN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase 1, Recruiting
Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)
for
Pancreatic Adenocarcinoma
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT04926467
Phase 2, Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for
Childhood Extracranial Germ Cell Tumor,
Location: Dallas TX, Fort Worth TX, Temple TX, Lawton OK,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT03067181
Phase 3, Recruiting
Analysis of Graft Function Following Autologous Islet Transplantation
for
Chronic Pancreatitis
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT03097185
Recruiting
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Dallas TX, Fort Worth TX, Temple TX, Austin TX,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT04684368
Phase 2, Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Location: Dallas TX, Fort Worth TX, Temple TX, Austin TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 5 - 60
Code: NCT05675410
Phase 3, Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Dallas TX, Fredericksburg TX, New Braunfels TX,
Sponsor: BriaCell Therapeutics Corporation
Sex: All
Age: 18+
Code: NCT06072612
Phase 3, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Dallas TX, Tyler TX, Shreveport LA, San Antonio TX,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Dallas TX, Nashville TN, Denver CO, Atlanta GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07226843
Phase 1, Recruiting
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
for
Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
Location: Dallas TX, San Antonio TX, Indianapolis IN,
Sponsor: Hummingbird Bioscience
Sex: All
Age: 18+
Code: NCT06956690
Phase 1, Phase 2, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Dallas TX, Round Rock TX, Austin TX, Hot Springs AR,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome
for
Hepatorenal Syndrome, Acute Kidney Injury
Location: Fort Worth TX, Nashville TN, Atlanta GA, Rochester MN,
Sponsor: River 2 Renal Corp.
Sex: All
Age: 18+
Code: NCT05875948
Phase 2, Recruiting
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine